N-[3-[[4-[2-[butyl-(4-methylphenyl)sulfonylamino]phenyl]sulfanyl-5-oxo-1-(2,4,6-trichlorophenyl)pyrazolidin-3-ylidene]amino]-4-chlorophenyl]tetradecanamide (CHEM353012)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-09-01 04:07:04 UTC | ||||||||
| Update Date | 2026-09-01 04:07:04 UTC | ||||||||
| Accession Number | CHEM353012 | ||||||||
| Identification | |||||||||
| Common Name | N-[3-[[4-[2-[butyl-(4-methylphenyl)sulfonylamino]phenyl]sulfanyl-5-oxo-1-(2,4,6-trichlorophenyl)pyrazolidin-3-ylidene]amino]-4-chlorophenyl]tetradecanamide | ||||||||
| Class | Small Molecule | ||||||||
| Description | N-[3-[[4-[2-[butyl-(4-methylphenyl)sulfonylamino]phenyl]sulfanyl-5-oxo-1-(2,4,6-trichlorophenyl)pyrazolidin-3-ylidene]amino]-4-chlorophenyl]tetradecanamide has the chemical formula C46H55Cl4N5O4S2. With an average molecular weight of 947.90 g/mol, N-[3-[[4-[2-[butyl-(4-methylphenyl)sulfonylamino]phenyl]sulfanyl-5-oxo-1-(2,4,6-trichlorophenyl)pyrazolidin-3-ylidene]amino]-4-chlorophenyl]tetradecanamide is a heavy molecule. | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C46H55Cl4N5O4S2 | ||||||||
| Average Molecular Mass | Not Available | ||||||||
| Monoisotopic Mass | 945.245 g/mol | ||||||||
| CAS Registry Number | Not Available | ||||||||
| IUPAC Name | N-[3-[[4-[2-[butyl-(4-methylphenyl)sulfonylamino]phenyl]sulfanyl-5-oxo-1-(2,4,6-trichlorophenyl)pyrazolidin-3-ylidene]amino]-4-chlorophenyl]tetradecanamide | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | CCCCCCCCCCCCCC(=O)NC1=CC(=C(C=C1)Cl)N=C2C(C(=O)N(N2)C3=C(C=C(C=C3Cl)Cl)Cl)SC4=CC=CC=C4N(CCCC)S(=O)(=O)C5=CC=C(C=C5)C | ||||||||
| InChI Identifier | InChI=1S/C46H55Cl4N5O4S2/c1-4-6-8-9-10-11-12-13-14-15-16-21-42(56)51-34-24-27-36(48)39(31-34)52-45-44(46(57)55(53-45)43-37(49)29-33(47)30-38(43)50)60-41-20-18-17-19-40(41)54(28-7-5-2)61(58,59)35-25-22-32(3)23-26-35/h17-20,22-27,29-31,44H,4-16,21,28H2,1-3H3,(H,51,56)(H,52,53) | ||||||||
| InChI Key | IGGDHKMBTOYBTD-UHFFFAOYSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
